162 related articles for article (PubMed ID: 10675369)
1. Experts debate value of HER2 testing methods.
Nelson NJ
J Natl Cancer Inst; 2000 Feb; 92(4):292-4. PubMed ID: 10675369
[No Abstract] [Full Text] [Related]
2. Accuracy and precision in HER2/neu testing in breast cancer: are we there yet?
Yaziji H; Gown AM
Hum Pathol; 2004 Feb; 35(2):143-6. PubMed ID: 14991529
[No Abstract] [Full Text] [Related]
3. How do you tell whether a breast cancer is HER2 positive? Ongoing studies keep debate in high gear.
Schmidt C
J Natl Cancer Inst; 2011 Jan; 103(2):87-9. PubMed ID: 21191114
[No Abstract] [Full Text] [Related]
4. HER2 testing recommendations in Australia.
Bilous M;
Pathology; 2001 Nov; 33(4):425-7. PubMed ID: 11827407
[TBL] [Abstract][Full Text] [Related]
5. Inconsistency of HER2 test raises questions.
Tuma RS
J Natl Cancer Inst; 2007 Jul; 99(14):1064-5. PubMed ID: 17623788
[No Abstract] [Full Text] [Related]
6. Human epidermal growth factor receptor 2 testing recommendation.
Raji A; Lurie RH
Arch Pathol Lab Med; 2007 Sep; 131(9):1330-1; author reply 1331-3. PubMed ID: 17824785
[No Abstract] [Full Text] [Related]
7. HER2--a discussion of testing approaches in the USA.
Thor A
Ann Oncol; 2001; 12 Suppl 1():S101-7. PubMed ID: 11521714
[TBL] [Abstract][Full Text] [Related]
8. Re: HER2 testing in the real world.
Vincent-Salomon A; MacGrogan G; Couturier J; Arnould L; Mathoulin-Pélissier S;
J Natl Cancer Inst; 2003 Apr; 95(8):628; author reply 628-9. PubMed ID: 12697858
[No Abstract] [Full Text] [Related]
9. [HER2 testing in breast cancer].
Yoshimura K
Nihon Rinsho; 2007 Jun; 65 Suppl 6():275-80. PubMed ID: 17682167
[No Abstract] [Full Text] [Related]
10. Trastuzumab administration associated with change in HER2 status.
Dawood S; Resetkova E; Gonzalez-Angulo AM
Clin Breast Cancer; 2008 Aug; 8(4):366-9. PubMed ID: 18757266
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of HER2 status in breast cancer].
Penault-Llorca F; Cayre A
Bull Cancer; 2004 Dec; 91 Suppl 4():S211-5. PubMed ID: 15899610
[TBL] [Abstract][Full Text] [Related]
12. Trastuzumab--mechanism of action and use in clinical practice.
Hudis CA
N Engl J Med; 2007 Jul; 357(1):39-51. PubMed ID: 17611206
[No Abstract] [Full Text] [Related]
13. HER2 testing and correlation with efficacy of trastuzumab therapy.
Fornier M; Risio M; Van Poznak C; Seidman A
Oncology (Williston Park); 2002 Oct; 16(10):1340-8, 1351-2; discussion 1352, 1355-8. PubMed ID: 12435204
[TBL] [Abstract][Full Text] [Related]
14. More than one way to look for HER2.
Check W
CAP Today; 1999 Mar; 13(3):1, 40-2, 46, passim. PubMed ID: 10350906
[No Abstract] [Full Text] [Related]
15. Herceptin (trastuzumab): adjuvant and neoadjuvant trials.
Yaal-Hahoshen N; Safra T
Isr Med Assoc J; 2006 Jun; 8(6):416-21. PubMed ID: 16833172
[No Abstract] [Full Text] [Related]
16. Breast cancer patients should not live without a HER-2/neu tissue result--but how safe can they live with it?
Lüftner D
Wien Klin Wochenschr; 2004 Jan; 116(1-2):3-5. PubMed ID: 15030116
[No Abstract] [Full Text] [Related]
17. How should HER2 status be determined?
McNeil C
J Natl Cancer Inst; 1999 Jan; 91(2):111. PubMed ID: 9923849
[No Abstract] [Full Text] [Related]
18. What is the ideal HER2 test for Herceptin therapy?
Jpn J Clin Oncol; 2000 Apr; 30(4):208-9, 211. PubMed ID: 10830993
[No Abstract] [Full Text] [Related]
19. Saving lives with accurate HER2 testing.
Ross JS
Am J Clin Pathol; 2010 Aug; 134(2):183-4. PubMed ID: 20660318
[No Abstract] [Full Text] [Related]
20. [Human recombinant anti-HER2 monoclonal antibody--a new targeted treatment in breast cancer].
Dank M
Orv Hetil; 2001 Nov; 142(46):2563-8. PubMed ID: 11770175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
